Aradhana Sarin
Presidente presso ACHILLION PHARMACEUTICALS, INC.
Patrimonio netto: 12 M $ in data 30/04/2024
Profilo
Il dott. Aradhana Sarin è presidente e direttore di Achillion Pharmaceuticals, Inc. e direttore finanziario e vicepresidente esecutivo di Alexion Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Achillion Pharmaceuticals, Inc. Il Dr. Sarin è stato precedentemente impiegato come direttore indipendente presso OraSure Technologies, Inc., MD-Healthcare Corporate & Investment Banking presso Citizens, Inc. (Austin, Texas), e di Managing Director-Healthcare Investment Banking di UBS AG. Ha ricevuto il suo MBA dalla Stanford Graduate School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ASTRAZENECA PLC
0.01% | 31/12/2023 | 82 514 ( 0.01% ) | 12 M $ | 30/04/2024 |
Ultime notizie su Aradhana Sarin
Posizioni attive di Aradhana Sarin
| Società | Posizione | Inizio |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Presidente | 28/01/2020 |
| ASTRAZENECA PLC | Direttore Finanziario/CFO | 01/08/2021 |
| ANHEUSER-BUSCH INBEV SA/NV | Direttore/Membro del Consiglio | 26/04/2023 |
Precedenti posizioni note di Aradhana Sarin
| Società | Posizione | Fine |
|---|---|---|
| CITIZENS, INC. | Corporate Officer/Principal | 01/10/2017 |
| UBS | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | - |
| ORASURE TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Aradhana Sarin
| Stanford Graduate School of Business | Masters Business Admin |
| University of Delhi | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| CITIZENS, INC. | Finance |
| ASTRAZENECA PLC | Health Technology |
| ANHEUSER-BUSCH INBEV SA/NV | Consumer Non-Durables |
| Aziende private | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
- Borsa valori
- Insiders
- Aradhana Sarin
